Bringing innovations and repurposed therapies to the marketplace is a group effort.
In partnership with other philanthropic groups, we often fund research programs, patient or scientific conferences, and genetic diagnosis. We also partner with other foundations to raise awareness about LGMD2I and other LGMDs.